Telomir Pharmaceuticals Announces Significant Anti-Cancer Effects in Prostate Cancer Animal Model Using Highly Aggressive Human Prostate Cancer Cells

About this update from Telomir Pharmaceuticals, Inc.

[{"type":"text","content":"Telomir-1 Inhibits Tumor Growth, Suppresses Cancer Progression, and Neutralizes Chemotherapy Toxicity","length":101,"tagName":"p"},{"type":"text","content":"MIAMI, FLORIDA / ACCESS Newswire / March 19, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir"), a leader in age-reversal science, today announced groundbreaking preclinical findings demonstrating that Telomir-1 reduces tumor size by approximately 50% in a prostate cancer animal model using highly aggressive human prostate cancer cells. It was found that Telomir-1 actively suppresses cancer growth rather than promoting it, and protects against chemotherapy-induced toxicity and mortality when combined with Paclitaxel-a widely used chemotherapy drug known for its effectiveness in treating various cancers but often associated with severe toxicity and side effects.","length":691,"tagName":"p"},{"type":"text","content":"Key findings include:","length":21,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Telomir-1 alone at both low and high doses reduced tumor growth by approximately 50%.","length":85,"tagName":"p"}]},{"val":[{"type":"text","content":"Contrary to concerns that telomere-elongating drugs may promote cancer, Telomir-1 demonstrated the opposite effect-actively suppressing tumor development, while selectively benefiting healthy cells.","length":198,"tagName":"p"}]},{"val":[{"type":"text","content":"In the group treated with Paclitaxel alone, severe toxicity was observed, leading to significant weight loss and mortality of one-third of the animals. However, when low-dose Telomir-1 was added to Paclitaxel, no mortality occurred.","length":232,"tagName":"p"}]}],"tagName":"ol","bulletedList":false,"length":515},{"type":"text","content":"Telomir-1 as a Chemotherapy Protector: The Potential Role of Oxidative Stress","length":77,"tagName":"p"},{"type":"text","content":"Paclitaxel and other chemotherapy agents induce toxicity largely through oxidative stress, which results in excessive damage to healthy cells and contributes to severe side effects. It is known that metal ions such as iron and copper play significant roles in amplifying the reactive oxygen species (ROS)-mediated effects of Paclitaxel, primarily through their involvement in redox chemistry and the Fenton reaction. We believe that Telomir-1's ability to reverse oxi...

More updates from Telomir Pharmaceuticals, Inc.